FibroGen Company

FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Connections from

Technology: Drug Delivery
Industry: Small&Large Molecules
Headquarters: San Francisco, California, United States
Founded Date: 1993
Employees Number: 251-500
Funding Status: IPO
Estimated Revenue: $10M to $50M

Visit Website
Register and Claim Ownership